Hemosmartmed Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2018

Location

Kunshan Jiangsu China

Primary Industry

Medical Devices & Equipment

About

Based in Jiangsu, China and founded in 2018, Hemosmartmed is a medical company that focuses on the development and production of vitro diagnostic microfluidic systems. The company has established virtual R&D centers at Cambridge University and Warwick University. The company has R&D centers in Pudong, Shanghai, and Cambridge, UK, and a production base in Kunshan, Suzhou. In addition, it owns more than 400 independent intellectual property rights and has obtained 55 NMPA registration certificates and 12 EU CE certificates. In October 2021, it closed a venture funding. At present, the company provides microfluidic control system development and production in the field of in vitro diagnosis as well as microfluidic technical consultancy services. Its business scope includes, automatic microdroplet high-speed production intelligent system, circulating tumor cell rapid screening system, microbial rapid detection kit, trace detection kit for misfolded protein in neurodegenerative diseases, and preparation of microcapsules. The company generates revenue by providing innovative diagnostic solutions, including automated rapid diagnostic equipment, microfluidic chips, and diagnostic reagent kits. The company will use the venture funding for product development and registration of medical rapid diagnostic products, as well as the establishment of a global marketing system.

Current Investors

SND Ventures Group, Kunshan Kersen Science & Technology Co., Ltd, Innovation Angel Funds

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Biopharmaceuticals, Diagnostic Equipment

Website

www.holosmed.com

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.